Esta página ha sido traducida por una máquina. Otras páginas pueden seguir apareciendo en inglés. View in English

Enfermedad renal cardiovascular metabólica: una nueva nomenclatura

  • 0Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.

|

|

Resumen

Este resumen es generado por máquina.

La enfermedad renal cardiovascular metabólica (Met-CVRD) se propone para definir mejor el síndrome, destacando la disfunción metabólica como el factor clave. La identificación temprana y la intervención con terapias como los agonistas de GLP-1 y los inhibidores de SGLT2 son cruciales para prevenir la progresión de la enfermedad.

Área De La Ciencia

  • Cardiología
  • Nefrología
  • Enfermedades metabólicas

Sus Antecedentes

  • La enfermedad renal cardiovascular (ERC) tradicionalmente describe las condiciones coexistentes.
  • La terminología existente pasa por alto el papel causal primario de las anomalías metabólicas.

Objetivo Del Estudio

  • Introducir el término Enfermedad renal cardiovascular metabólica (Met-CVRD) para enfatizar la disfunción metabólica como la patogénesis principal.
  • Abogar por la identificación temprana y las estrategias de intervención para Met-CVRD.

Principales Métodos

  • Revisión de la comprensión actual de las interrelaciones entre la DRCV y la diabetes tipo 2.
  • Identificación de los principales procesos metabólicos aguas arriba que provocan daño cardíaco y renal.

Principales Resultados

  • Perturbaciones metabólicas (resistencia a la insulina, inflamación, etc.) son fundamentales para el desarrollo de la ERC, que a menudo preceden a los signos clínicos.
  • Existe una relación bidireccional, impulsada por el metabolismo, entre el corazón y los riñones.

Conclusiones

  • El término Met-CVRD refleja con precisión la patología subyacente.
  • Es esencial dar prioridad a la detección temprana y al tratamiento con agentes protectores cardiorenales (por ejemplo, agonistas de GLP-1, inhibidores de SGLT2) para un tratamiento proactivo.

Videos de Conceptos Relacionados

Cardiomyopathy I: Introduction and Classification 01:25

50

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...

Continuous Renal Replacement Therapy 01:30

129

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...

Cardiovascular Drugs: Classification based on Therapeutic Indications 01:18

3.2K

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...

Cardiomyopathy IV: Restrictive Cardiomyopathy 01:29

27

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Imaging Studies for Cardiovascular System IV: CMRI 01:21

135

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...

Heart Failure IV: Classification and Diagnostic Evaluation 01:30

32

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...